Grey Cloak Tech, Inc. (OTCQB: GRCK) today announced that its board of directors has decided to abandon and cancel the reverse stock split that was previously approved by both the board and the company’s shareholders in February 2017.
Cannabis News
Algae Dynamics Corp. (ADYNF) Continues Collaborative Research on Safer Cannabinoid Delivery
Innovative biotech company Algae Dynamics Corp. (OTCQB: ADYNF) is engaged in the development of nutraceuticals and pharmaceuticals utilizing hemp, cannabis and algae oils.
Global Payout, Inc. (GOHE) Enters Final Stages of Audit in Preparation for Uplisting to OTCQB Venture Marketplace
Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that it is in the final stages of performing a two-year audit in an effort to become a fully reporting SEC company.
Global Payout, Inc. (GOHE) Subsidiary Sells Front Cover of First PotSaver Los Angeles Edition
MoneyTrac Technology, Inc. has successfully sold the front cover of PotSaver’s premier Los Angeles edition, which is slated for release and mass distribution on January 1, 2018.
Grey Cloak Tech, Inc. (GRCK) Acquires Eqova Life Sciences
Grey Cloak Tech, Inc. (OTCQB: GRCK) this morning announced that it has acquired Eqova Life Sciences, a medically-focused CBD company, in an all-stock transaction.
Copy of Global Payout, Inc. (GOHE) Subsidiary Sells Front Cover of First PotSaver Los Angeles Edition
MoneyTrac Technology, Inc. has successfully sold the front cover of PotSaver’s premier Los Angeles edition, which is slated for release and mass distribution on January 1, 2018.
InMed Provides Updates On Cannabinoid-Based Drug Therapies For The Treatment Of Pain
InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF), announced today additional pre-clinical results in the development of INM-405 for the treatment of pain.
Canopy Growth Applauds Action by TSX to Confirm That Listed Companies Should Not be Engaging in Federally Illegal US Cannabis Activities
TSX Staff Notice on Marijuana Validates Canopy's Longstanding Market Strategy to Protect Investors by Conducting Business Only Where it is Federally Legal to Do So; Should Bring Clarity and Relief to Investors Seeking to Participate in Listed and Compliant Cannabis Companies
EVIO, Inc. (EVIO) Prepares for New Cannabis Testing Rules in California Ahead of January Recreational Legalization
EVIO, Inc. (OTCQB: EVIO) is readying itself for new testing rules in California, which it foresees as the largest cannabis marketplace in the world.
Marijuana Company of America (MCOA) Uniquely Positioned for Cannabis and Hemp Industry Innovation
In this competitive market, companies such as Marijuana Company of America, Inc. (OTC: MCOA) are successfully carving out a niche for themselves due to a unique strategic approach and business model.
Standout Players Find Varied, Innovative Means of Serving the Marijuana Industry
Standouts in the diverse cannabis industry include Global Payout, Inc. (GOHE)...
Aurora Cannabis Announces $6 Million Private Placement
Aurora Cannabis Inc. has agreed to a one-time special accommodation for the benefit of its underwriters due to very significant demand for the Bought Deal, to proceed with a concurrent, non-commissioned, non-brokered private placement of up to 2,000,000 units of the Company (the "Units") at a price of $3.00 per Unit (the "Offering").
Cannabis Wheaton Announces Strategic Alliance With Large Convenience Store Group
Cannabis Wheaton Income Corp. (TSX VENTURE: CBW) announceS that it has entered an exclusive strategic alliance with the corporate owner of a national chain of convenience stores to develop and implement cannabis distribution and retail sale opportunities at all Convenience Store Group locations.
Plus Receives $2M Series A for Cannabis-Infused Products
Plus, the cannabis infused products manufacturer, is pleased to announce the closing of its Series A financing. The Financing was comprised of $2 Million USD of Series A Preferred Stock (the “Shares”), and was led by The Green Opportunity Funds.
Taking Stock of InMed - InMed President and CEO Eric Adams Sits Down For Two In-Depth Interviews
InMed Pharmaceuticals Inc. (CNSX:IN) (OTCMKTS:IMLFF) CEO Eric Adams recently sat down for two separate interviews regarding InMed's proprietary biosynthesis process, their patent filings and their research on using cannabinoids to treat various diseases.